CVE-2024-1708: ConnectWise ScreenConnect Path Traversal Vulnerability

CISA Known Exploited Vulnerabilities

Name

ConnectWise ScreenConnect Path Traversal Vulnerability

Vendor

ConnectWise

Product

ScreenConnect

Added to the catalog

2026-04-28

Due date for US federal agencies

2026-05-12

Weaknesses

CWE-22

Catalog version

2026.10.30

ConnectWise ScreenConnect contains a path traversal vulnerability which could allow an attacker to execute remote code or directly impact confidential data and critical systems.

Required action (CISA)

Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

Ransomware use: CISA marks this vulnerability as known to be used in ransomware campaigns. CISA does not say which group used it.

Links in CISA's notes

• https://www.connectwise.com/company/trust/security-bulletins/connectwise-screenconnect-23.9.8
• https://nvd.nist.gov/vuln/detail/CVE-2024-1708

Read on 2026-11-02T23:39:54.475Z under licence cisa-kev-cc0@b0067899 from https://www.cisa.gov/sites/default/files/feeds/known_exploited_vulnerabilities.json

NVD analysis

Status

Analyzed

Published

2024-02-21T16:15:50.233

Last modified

2026-06-17T07:04:50.430

Weaknesses

CWE-22

ConnectWise ScreenConnect 23.9.7 and prior are affected by path-traversal vulnerability, which may allow an attacker

the ability to execute remote code or directly impact confidential data or critical systems.

References

• https://www.connectwise.com/company/trust/security-bulletins/connectwise-screenconnect-23.9.8 (Vendor Advisory)
• https://www.huntress.com/blog/a-catastrophe-for-control-understanding-the-screenconnect-authentication-bypass (Exploit, Third Party Advisory)
• https://www.connectwise.com/company/trust/security-bulletins/connectwise-screenconnect-23.9.8 (Vendor Advisory)
• https://www.huntress.com/blog/a-catastrophe-for-control-understanding-the-screenconnect-authentication-bypass (Exploit, Third Party Advisory)
• https://www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2024-1708 (Third Party Advisory, US Government Resource)
• https://www.microsoft.com/en-us/security/blog/2026/04/06/storm-1175-focuses-gaze-on-vulnerable-web-facing-assets-in-high-tempo-medusa-ransomware-operations/ (Technical Description)

This product uses the NVD API but is not endorsed or certified by the NVD.

Read on 2026-11-02T23:42:15.686Z under licence nvd-api-terms-of-use@ff2a5288 from https://services.nvd.nist.gov/rest/json/cves/2.0?cveId=CVE-2024-1708

CVE record

Title (CNA)

Improper limitation of a pathname to a restricted directory (“path traversal”)

Assigner

cisa-cg

State

PUBLISHED

Published

2024-02-21T15:29:10.091Z

Updated

2026-08-04T03:55:56.405Z

Problem types

CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

ConnectWise ScreenConnect 23.9.7 and prior are affected by path-traversal vulnerability, which may allow an attacker

the ability to execute remote code or directly impact confidential data or critical systems.

References

• https://www.connectwise.com/company/trust/security-bulletins/connectwise-screenconnect-23.9.8
• https://www.huntress.com/blog/a-catastrophe-for-control-understanding-the-screenconnect-authentication-bypass

Read on 2026-11-03T02:05:36.539Z under licence cve-terms-of-use@81bfa2f3 from https://raw.githubusercontent.com/CVEProject/cvelistV5/main/cves/2024/1xxx/CVE-2024-1708.json

Detection rules (SigmaHQ)

SigmaHQ rules whose own tags name this CVE. Each rule page shows the rule as its author published it.

• CVE-2024-1708 - ScreenConnect Path Traversal Exploitation (status test, level medium)
• CVE-2024-1708 - ScreenConnect Path Traversal Exploitation - Security (status test, level critical)

Defensive techniques (MITRE D3FEND)

D3FEND maps these defensive techniques to the weakness (CWE) that NVD lists for this CVE, through the digital artifacts the weakness affects. D3FEND does not say they stop this vulnerability.

MITRE D3FEND™ knowledge graph. © 2025 The MITRE Corporation.
"The MITRE Corporation (MITRE) hereby grants you a non-exclusive, royalty-free license to use D3FEND for research, development, and commercial purposes. Any copy you make for such purposes is authorized provided that you reproduce MITRE's copyright designation and this license in any such copy." Terms: https://d3fend.mitre.org/tou/